|
|
Researchers connect allergic and autoimmune diseases to find target for cancer therapy |
|
|
| Research institutes
: 05 June, 2013 |
|
A group of scientists from the US National Institutes of Health and Sidra Medical and Research Center discover that a gene called Bach2 may play a central role in the development of a range of allergic and autoimmune diseases, such as multiple sclerosis, asthma, Crohn's disease, celiac disease, and type-1 diabetes. |
| |
|
|
|
 |
|
|
|
|
|
EPSRC invests into research projects set to make phones, probes and sensors transform healthcare |
|
|
|
| Development services
: 09 May, 2013 |
|
A £32 million investment from the Engineering and Physical Sciences Research Council is going to establish three new Healthcare Interdisciplinary Research Collaborations (IRCs) which will fund several innovative projects including: smart-phone test and tracking systems for infectious diseases; fibre optic probes that can monitor people's condition in intensive care; and in-home sensors that can relay patient information to doctors immediately. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Study into home monitoring for CF patients is expanded |
|
|
|
| Research studies
: 05 February, 2013 |
|
ERT together with pulmonary researchers at the Johns Hopkins University School of Medicine and University of Washington, are expanding the Early Intervention in Cystic Fibrosis Exacerbation (eICE) Study. |
| |
|
|
|
|
|
|
|
|
|
Life Technologies sets up international influenza network to monitor vaccine development |
|
|
|
| Development services
: 31 January, 2013 |
|
Life Technologies is establshing the Global Influenza Network, a partnership including scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nanoparticles technology aims to offer earlier cancer diagnosis solution |
|
|
|
| Research institutes
: 18 December, 2012 |
|
A new technology developed at MIT aims to help to make biomarker detection much easier with researchers, led by Sangeeta Bhatia, developing nanoparticles that can home in on a tumour and interact with cancer proteins to produce thousands of biomarkers, which can then be easily detected in the patient's urine. |
| |
|
|
|
|
|
|
|
|
|
|
|
New injectable gels from MIT toughen up after entering the body |
|
|
|
| Research institutes
: 20 November, 2012 |
|
MIT chemical engineers have now designed an injectable gel that responds to the body's high temperature by forming a reinforcing network that makes the gel much more durable, allowing it to function over a longer period of time. |
| |
|
|
|
|
|
|
|
|
|
Algometron seeks partners to develop pain test that stratifies patients for optimal therapy |
|
|
|
| Development services
: 23 October, 2012 |
|
A novel patented technology (Algotect) has been developed by Algometron to accurately identify patients who are cold hyperalgesic and require specific pain management and Algometron is seeking partners interested in commercially developing (RUO, IVD, LDT, CDx) the innovative and proven device which provides real time, cost effective information to support clinicians, research, drug development and clinical trials. |
| |
|
|
|
|
|
|
|
Diamyd Medical divests US gene therapy company |
|
|
|
| Development services
: 10 October, 2012 |
|
Diamyd Medical enters into an agreement for the sale of the US subsidiary, Diamyd, involved in drug development primarily relating to the NTDDS platform with applications in pain and neuropathy among others. |
| |
|
|
|
|
|
|
|
|
|
|
|
Neuralstem completes Phase I ALS stem cell trial |
|
|
|
| Research studies
: 29 August, 2012 |
|
Neuralstem completes the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Research shows success of engineered tissue depends on where it is grown |
|
|
|
| Research studies
: 15 August, 2012 |
|
MIT researchers led by Elazer Edelman, the Thomas D and Virginia W Cabot Professor of Health Sciences and Technology, are showing that implanted cells' therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. The work could allow scientists to develop even more effective implants and also target many other diseases, including cancer. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CDISC releases new Protocol Representation Model toolkit |
|
|
|
| Research institutes
: 23 April, 2012 |
|
The Clinical Data Interchange Standards Consortium (CDISC) is releasing the first iteration of a Protocol Representation 'Toolkit' for clinical research at the CDISC European Interchange Conference in Stockholm, Sweden. |
| |
|
|
|
|
|
|
|
Largest Warfarin patient self-testing study points to new standard of care |
|
|
|
| Research studies
: 29 March, 2012 |
|
Alere reveals at the 2012 American College of Cardiology Summit the results from the world's largest study of warfarin (Coumadin) patient self-testers, performed by anticoagulation expert, Jack Ansell, MD, which showed that self-testing led to excellent therapy control. |
| |
|
|
|
|
|
|
|
|
|
Study finds chronic pain patients benefit from education |
|
|
|
| Research studies
: 28 February, 2012 |
|
A study conducted at Mayo Pain Rehabilitation Center, Rochester, Maine, USA by Sarah Hayes and Michael Hooten, MD, Associate Professor of Anesthesiology at Mayo Clinic shows that substance use education incorporated into a cognitive behavioural rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse. |
| |
|
|
|
|
|
|
|
Illumina introduces new cancer analysis service |
|
|
|
| Development services
: 20 February, 2012 |
|
Illumina launches a Cancer Analysis Service from the Illumina Genome Network (IGN) that applies the high accuracy of Illumina technologies to provide cancer researchers with easily interpretable tumour/normal sequencing data to quickly move their research forward. |
| |
|
|
|
|
|
|
|
Scottish Government forges research strategic alliance with PPD |
|
|
|
| Development services
: 13 February, 2012 |
|
The Scottish government and Pharmaceutical Product Development (PPD) is forming an alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance health care treatment options for the people of Scotland.
|
| |
|
|
|
|
|
|
|
|
|
New indicator selects patients with increased throat cancer risk |
|
|
|
| Research studies
: 17 January, 2012 |
|
Researchers at the University of Michigan Health System discover a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies. |
| |
|
|
|
|
|
|
|
British Columbia Cancer Agency joins the Illumina Genome Network |
|
|
|
| Development services
: 20 December, 2011 |
|
The British Columbia Cancer Agency's (BCCA) Genome Science Center is joining the Illumina Genome Network (IGN) which is designed to link researchers needing large-scale whole human genome sequencing with leading institutions that provide this application as a service using industry-leading Illumina sequencing platforms. |
| |
|
|
|
|
|
|
|
Research centre for blast injury studies is launched |
|
|
|
| Research institutes
: 09 December, 2011 |
|
The Royal British Legion Centre for Blast Injury Studies at Imperial College London is a new £8 million research centre being launched which aims to gain a better understanding of the injuries caused by roadside bombs and improve both treatment and the means of protection. |
| |
|
|
|
|
|
|
|
Cancer research study to target tumour-secreted exosomes |
|
|
|
| Research studies
: 07 December, 2011 |
|
Aethlon Medical is reporting that a cancer research study to test the ex vivo effectiveness of the Aethlon Hemopurifier to capture tumour-secreted exosomes from the blood of advanced-stage cancer patients has received institutional review board approval to begin studies at the Sarcoma Oncology Center, based in Santa Monica, California, USA. |
| |
|
|
|
|
|
|
|
Zimmer to open research and development centre in Beijing |
|
|
|
| Development services
: 05 December, 2011 |
|
Zimmer plans to establish a new research and development centre in Beijing, China with the centre becoming the foundation for a network of research and development programs across the region. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Personalized medicine study yields clues about patient engagement |
|
|
|
| Research studies
: 18 October, 2011 |
|
The Medco Research Institute, the research subsidiary of Medco Health Solutions, and Quest Diagnostics are reporting their study showed a statistically significant increase in adherence to statin therapy over six months in patients receiving kinesin-like protein 6 (KIF6) gene testing, compared with those who did not. |
| |
|
|
|
|
|
| First | Prev | 1 | 2 | 3 | 4 | 5 | Next | Last |
